As of Feb 17
| +0.34 / +0.76%|
The 2 analysts offering 12-month price forecasts for Medifast Inc have a median target of 44.00, with a high estimate of 51.00 and a low estimate of 37.00. The median estimate represents a -2.37% decrease from the last price of 45.07.
The current consensus among 2 polled investment analysts is to Buy stock in Medifast Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.